
To evaluate the effects of l-arginine supplementation on Doppler indices of cardiopulmonary hemodynamics in children with sickle cell anaemia experiencing pain. A greater reduction in median TRV occurred in the arginine group than placebo. In addition, a larger percentage increase in global arginine bioavailability was associated with a lower TRV after 5 days of supplementation. Oral arginine supplementation improves cardiopulmonary hemodynamics during sickle cell disease, vasoocclusive pain and ACS.
Like
Save
Share